Global Biobanking Market Research Report 2019: Industry Analysis and Forecast to 2024 - Growing Trend of Preserving Cord Blood Cells of New-Borns

DUBLIN, Sept. 25, 2019 /PRNewswire/ -- The "Biobanking Market Research Report: By Offering, Sample Type, Storage Type, Application, Utility, Regional Insight - Industry Analysis and Forecast to 2024" report has been added to's offering.

The market valued $25.8 billion in 2018 and is expected to grow to $36.8 billion by 2024 at a 6.2% CAGR during the forecast period (2019-2024).

The major drivers for the biobanking market include the need for cost-effective drug discovery and development, rising prevalence of chronic diseases, increasing funding, and surging genomic research activities. Biobanking refers to the storage, analysis, processing, and transportation of samples and specimens obtained from humans, such as blood, genetic material, and excreta, for the purpose of clinical research.

On the basis of offering, the worldwide biobanking market is categorized into equipment, consumables, software, and services. Among these, the consumables category dominated the market during the historical period (2014-2018) and is predicted to continue its dominance throughout the forecast period with an over 40.0% revenue share in 2024. The reason for this is that consumables have to be purchased regularly, whereas software and equipment are only purchased once.

Clinical research, regenerative medicine, and life science and medical research are the primary applications of biobanking. Among these, clinical research generated 49.2% of the total revenue for the biobanking market in 2018, and it will still be the largest application during the forecast period. This is ascribed to the increasing need to established the safety and efficiency of drugs, medical devices, and other products used in the healthcare sector. The fastest growth in the forecast period is expected to be witnessed by the regenerative medicine application.

A key driver for the growth of the market is the increase in the incidence of chronic diseases. Obesity, high cholesterol, poor nutrition, tobacco consumption, lack of physical activity, and elevated blood pressure have been tied to four of the most rampant chronic diseases - cancer, cardiovascular diseases, chronic obstructive pulmonary disease, and type 2 diabetes. As per the Centers for Disease Control and Prevention, almost 60.0% of the total population in the U.S. has at least one chronic disease.

Key Topics Covered:

Chapter 1. Research Background

Chapter 2. Research Methodology

Chapter 3. Executive Summary

Chapter 4. Introduction
4.1 Market Definition
4.1.1 By Offering Consumables Storage Analysis Processing Collection Equipment Storage Analysis Processing Transport Services Storage Processing and analysis Transport Software
4.1.2 By Sample Type Blood products and genetic material Human tissues Cell lines Biological fluids Human waste products
4.1.3 By Storage Type Manual Automated
4.1.4 By Application Clinical research Life science and medical research Regenerative medicine
4.1.5 By Utility Research Routine Epidemiology
4.2 Market Dynamics
4.2.1 Trends Growing trend of preserving cord blood cells of new-born
4.2.2 Drivers Increasing prevalence of chronic conditions Growing funding support to biobanks Increase in genomic research activities for studying diseases Increasing need for cost-effective drug discovery and development Impact analysis of drivers on market forecast
4.2.3 Restraints Issues related to procurement of biospecimen sample Impact analysis of restraints on market forecast
4.2.4 Opportunities Growing focus on the R&D of cell therapies
4.3 Porter's Five Forces Analysis
4.3.1 Bargaining Power of Buyers
4.3.2 Bargaining Power of Suppliers
4.3.3 Intensity of Rivalry
4.3.4 Threat of New Entrants
4.3.5 Threat of Substitutes
4.4 Regulatory Overview
4.4.1 Europe Biobank Act of Finland Swiss Biobanking Platform (SBP) of Switzerland U.K. Biobank
4.4.2 North America

Chapter 5. Global Market Size and Forecast
5.1 By Offering
5.1.1 Biobanking Consumables Market, by Type
5.1.2 Biobanking Equipment Market, by Type
5.1.3 Biobanking Services Market, by Type
5.2 By Sample Type
5.3 By Storage Type
5.4 By Application
5.5 By Utility
5.6 By Region

Chapter 6. North America Market Size and Forecast

Chapter 7. Europe Market Size and Forecast

Chapter 8. APAC Market Size and Forecast

Chapter 9. LATAM Market Size and Forecast

Chapter 10. MEA Market Size and Forecast

Chapter 11. Major Markets
11.1 U.S.
11.2 Canada
11.3 Germany
11.4 France
11.5 U.K.
11.6 Spain
11.7 Italy
11.8 Japan
11.9 China
11.10 India

Chapter 12. Competitive Landscape
12.1 Company Benchmarking Based on Product Offerings
12.2 Strategic Development of the Key Players
12.2.1 Product Launches
12.2.2 Acquisitions
12.2.3 Collaborations

Chapter 13. Company Profiles


    --  Thermo Fisher Scientific Inc.
    --  Merck KGaA
    --  Promega Corporation
    --  Becton, Dickinson and Company
    --  Hamilton Company
    --  Avantor Inc.
    --  Tecan Group Ltd.
    --  QIAGEN N.V.
    --  PHC Holdings Corporation
    --  Brooks Automation Inc.
    --  AutoGen Inc.
    --  BioCision
    --  BioLife Solutions Inc.

Service Providers

    --  AlphaCord LLC
    --  BioKryo GmbH
    --  Cryo-Cell International Inc.

For more information about this report visit

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

Media Contact:

Research and Markets
Laura Wood, Senior Manager

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

View original content:

SOURCE Research and Markets